MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.00 (0.00%)
Close on Nov 13, 2026Market cap $8.56MP/E –Yield –
MetaVia cash
Cash and short-term investments held at the end of each period.
MetaVia's cash was $8.78M at Sep 30, 2026. For fiscal 2025 it was $10.28M, down 35.8% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $33.36M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.28M | -35.8% |
| FY2024 | Dec 31, 2024 | $16.02M | -28.6% |
| FY2023 | Dec 31, 2023 | $22.44M | -32.8% |
| FY2022 | Dec 31, 2022 | $33.36M | +103.6% |
| FY2021 | Dec 31, 2021 | $16.39M | +62.4% |
| FY2020 | Dec 31, 2020 | $10.09M | -27.5% |
| FY2019 | Dec 31, 2019 | $13.92M | +389.4% |
| FY2018 | Dec 31, 2018 | $2.85M | +5590.0% |
| FY2017 | Dec 31, 2017 | $50.00K | -99.8% |
| FY2016 | Dec 31, 2016 | $24.03M | +563.9% |
| FY2015 | Dec 31, 2015 | $3.62M | +1042.0% |
| FY2014 | Dec 31, 2014 | $317.00K | +10466.7% |
| FY2013 | Dec 31, 2013 | $3.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.78M | -38.5% |
| Q2 FY2026 | Jun 30, 2026 | $12.63M | -28.2% |
| Q1 FY2026 | Mar 31, 2026 | $13.73M | +22.7% |
| Q4 FY2025 | Dec 31, 2025 | $10.28M | -35.8% |
| Q3 FY2025 | Sep 30, 2025 | $14.28M | -34.1% |
| Q2 FY2025 | Jun 30, 2025 | $17.59M | -37.0% |
| Q1 FY2025 | Mar 31, 2025 | $11.19M | -30.0% |
| Q4 FY2024 | Dec 31, 2024 | $16.02M | -28.6% |
| Q3 FY2024 | Sep 30, 2024 | $21.67M | -16.1% |
| Q2 FY2024 | Jun 30, 2024 | $27.93M | -2.6% |
| Q1 FY2024 | Mar 31, 2024 | $15.99M | -48.1% |
| Q4 FY2023 | Dec 31, 2023 | $22.44M | -32.8% |
| Q3 FY2023 | Sep 30, 2023 | $25.84M | +306.5% |
| Q2 FY2023 | Jun 30, 2023 | $28.69M | +224.2% |
| Q1 FY2023 | Mar 31, 2023 | $30.81M | +166.6% |
| Q4 FY2022 | Dec 31, 2022 | $33.36M | +103.6% |
| Q3 FY2022 | Sep 30, 2022 | $6.36M | -9.0% |
| Q2 FY2022 | Jun 30, 2022 | $8.85M | -7.0% |
| Q1 FY2022 | Mar 31, 2022 | $11.56M | -11.3% |
| Q4 FY2021 | Dec 31, 2021 | $16.39M | +62.4% |
| Q3 FY2021 | Sep 30, 2021 | $6.98M | -43.5% |
| Q2 FY2021 | Jun 30, 2021 | $9.51M | -33.5% |
| Q1 FY2021 | Mar 31, 2021 | $13.04M | +33.0% |
| Q4 FY2020 | Dec 31, 2020 | $10.09M | -27.5% |
| Q3 FY2020 | Sep 30, 2020 | $12.35M | -41.5% |
| Q2 FY2020 | Jun 30, 2020 | $14.30M | +290.9% |
| Q1 FY2020 | Mar 31, 2020 | $9.80M | +77.4% |
| Q4 FY2019 | Dec 31, 2019 | $13.92M | +389.4% |
| Q3 FY2019 | Sep 30, 2019 | $21.13M | -11.3% |
| Q2 FY2019 | Jun 30, 2019 | $3.66M | -87.0% |
| Q1 FY2019 | Mar 31, 2019 | $5.53M | -84.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.85M | +5590.0% |
| Q3 FY2018 | Sep 30, 2018 | $23.81M | -6.1% |
| Q2 FY2018 | Jun 30, 2018 | $28.04M | +24.7% |
| Q1 FY2018 | Mar 31, 2018 | $34.46M | +17.7% |
| Q4 FY2017 | Dec 31, 2017 | $50.00K | -99.8% |
| Q3 FY2017 | Sep 30, 2017 | $25.34M | – |
| Q2 FY2017 | Jun 30, 2017 | $22.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.03M | – |
See a number that looks wrong?